Report Description

Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes. In 2009, according to WHO, 214 Mn to 397 Mn clinical malaria cases were reported worldwide. However, high estimates of around 515 Mn clinical cases of P. falciparum were projected in 2002. Furthermore, malaria accounted for around 3% of the world’s total Disability Adjusted Life Years (DALYs) lost and around 10% in Africa alone. According to Centers for Disease Control and Prevention (CDC), there are around 156 types of Plasmodium species that infect various species of vertebrates. Among the numerous plasmodium species, four are considered true parasites of humans, as they utilize humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Over 85% of malaria mortality is due to P. falciparum. Around 90% of deaths caused by malaria in Sub-Saharan Africa is primarily due to P. falciparum.


The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market. According to World Health Organization (WHO), in 2015, approximately 292,000 children in Africa died of malaria, at very early age of 5 years. Around 306,000 fatalities associated with malaria were reported worldwide in 2015, out of which around 90% cases were reported in Africa. According to World Health Organization (WHO), first global malaria vaccines will be piloted in the regions of sub-Saharan Africa in 2018, with the funding to around US$ 15 Mn. The program is partly funded by the Bill & Melinda Gates Foundation and African Research Centers. Major regions affected by malaria do not have an appropriate healthcare infrastructure and standard economic conditions, due to which they are unable to pay for the better treatments and drugs. Malaria is common in sub-Saharan and African region, due to poor sanitation and healthcare standards. However, the vaccine is being developed by GSK at their lab in Belgium in collaboration with Path, which is an international non-profit organization. This ensures the cost effectiveness of the vaccine though it has taken around 30 years to develop at a cost of US$ 565 Mn. The company pledges not to make a profit from sales of the vaccine and adheres to the price range of around US$ 5 per shot.
Market Taxonomy
This report segments the global malaria vaccines market on the basis of vaccines type, by agent, distribution channel, and geography. On the basis of vaccines type, the malaria vaccines market is categorized into Pre-Erythrocytic Vaccine, Erythrocytic Vaccine and Multi-antigen Vaccine. On the basis of agent, the malaria vaccines market is categorized into Plasmodium Falciparum and Plasmodium Vivax. On the basis of distribution channel, the malaria vaccines market is categorized into hospital, clinics, and community centers. For comprehensive understanding of market dynamics, the global malaria vaccines market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:
• This report provides in-depth analysis of the malaria vaccines and is its use, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2024, considering 2018 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global malaria vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, Distribution Channel strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
• The global malaria vaccines market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for malaria vaccines market, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the malaria vaccines market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Malaria Vaccines Market, By Vaccines Type:
•·Pre-Erythrocytic Vaccine
•·Erythrocytic Vaccine
•·Multi-antigen Vaccine
• Global Malaria Vaccines Market, By Agent:
•·Plasmodium Falciparum
•·Plasmodium Vivax
• Global Malaria Vaccines Market, By Distribution Channel:
•·Hospitals
•·Clinics
•·Community Centers
• Global Malaria Vaccines Market, By Geography:
•·North America
o U.S.
o U.S. Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o U.S. Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o U.S. Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Canada
o Canada Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Canada Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Canada Malaria Vaccines Market, By Distribution Channel :
o Hospitals
o Clinics
o Community Centers
•·Europe
o U.K.
o Europe Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Europe Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Europe Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Germany
o Germany Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Germany Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Germany Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Italy
o Italy Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Italy Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Italy Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o France
o France Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o France Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o France Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Spain
o Spain Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Spain Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Spain Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Russia
o Russia Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Russia Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Russia Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Rest of Europe
o Rest of Europe Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Rest of Europe Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Rest of Europe Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
•·Asia-Pacific
o China
o China Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o China Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o China Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o India
o India Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o India Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o India Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Japan
o Japan Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Japan Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Japan Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o ASEAN
o ASEAN Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o ASEAN Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o ASEAN Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o
o Australia
o Australia Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Australia Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Australia Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o South Korea
o South Korea Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o South Korea Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o South Korea Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Rest of Asia Pacific
o Rest of Asia Pacific Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Rest of Asia Pacific Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Rest of Asia Pacific Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
•·Latin America
o Brazil
o Brazil Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Brazil Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Brazil Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Mexico
o Mexico Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Mexico Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Mexico Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Rest of Latin America
o Rest of Latin America Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Rest of Latin America Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Rest of Latin America Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
•·Middle East
o GCC
o GCC Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o GCC Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o GCC Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Israel
o Israel Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Israel Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Israel Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Rest of Middle East
o Rest of Middle East Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Rest of Middle East Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Rest of Middle East Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
•·Africa
o North Africa
o North Africa Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o North Africa Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o North Africa Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o Central Africa
o Central Africa Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o Central Africa Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o Central Africa Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
o South Africa
o South Africa Malaria Vaccines Market, By Vaccines Type:
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-antigen Vaccine
o South Africa Malaria Vaccines Market, By Agent:
o Plasmodium Falciparum
o Plasmodium Vivax
o South Africa Malaria Vaccines Market, By Distribution Channel:
o Hospitals
o Clinics
o Community Centers
• Company Profiles
•·GlaxoSmithKline plc *
o Company Overview
o Product Portfolio
o Financial Performance
o Key Strategies
o Recent Developments
o Future Plans
•·Sanaria Inc.
•·Nobelpharma Co., Ltd.
•·Sumaya Biotech
•·GenVec, Inc.
“*” marked represents similar segmentation in other categories in the respective section.